RP Management, LLC

Holdings History for BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

Symbol: BCRX on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-21%	$0	0	-3,846,154	-100%	$7.90	Q2 2025
31 Mar 2025	21%	0%	$28,846,155	3,846,154	0		$7.50	Q1 2025
31 Dec 2024	36%	0%	$29,230,770	3,846,154	0		$7.60	Q4 2024
30 Sep 2024	13%	0%	$29,230,770	3,846,154	0		$7.60	Q3 2024
30 Jun 2024	13%	0%	$23,769,232	3,846,154	0		$6.18	Q2 2024
31 Mar 2024	11%	0%	$19,538,462	3,846,154	0		$5.08	Q1 2024
31 Dec 2023	15%	0%	$23,038,463	3,846,154	0		$5.99	Q4 2023
30 Sep 2023	26%	0%	$27,230,770	3,846,154	0		$7.08	Q3 2023
30 Jun 2023	28%	0%	$27,076,924	3,846,154	0		$7.04	Q2 2023
31 Mar 2023	44%	0%	$32,076,924	3,846,154	0		$8.34	Q1 2023
31 Dec 2022	52%	0%	$44,153,847	3,846,154	0		$11.48	Q4 2022
30 Sep 2022	22%	0%	$48,462,000	3,846,154	0		$12.60	Q3 2022
30 Jun 2022	16%	0%	$40,692,000	3,846,154	0		$10.58	Q2 2022
31 Mar 2022	32%	0%	$62,538,000	3,846,154	0		$16.26	Q1 2022
31 Dec 2021	20%	+20%	$43,000,000	3,846,154	+3,846,154	NEW	$11.18	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.